Significance of plasma 1，3-beta-D-glucan assay for the diagnosis of invasive fungal diseases in patients with malignant hematological diseases

doi:10.3969/j.issn.1673-8640.2013.01.002

Abstract

Abstract: Objective　To evaluate the significance of plasma 1，3-beta-D-glucan assay(G test)for the diagnosis of invasive fungal diseases（IFD）in patients with malignant hematological diseases. Methods　A retrospective analysis was performed in 220 inpatients with malignant hematological trmor．According to Diagnostic Criteria and Principles of Treatment of Invasive Fungal Infections in Patients with Blood Diseases/Malignancies as gold standard，the plasma 1，3-beta-D-glucan concentration′s area under the receiver operating characteristic（ROC）curve，sensitivity，specificity and time to diagnosis in the diagnosis of IFD were analyzed. Results　Comparing the gold standard，the plasma 1，3-beta-D-glucan concentration′s area under the ROC curve，sensitivity，specificity and time to diagnosis were 0.946 1，98.6%，83.0% and（3.86±2.92)d，respectively. Conclusions　G test has good sensitivity and time to diagnosis for the diagnosis of IFD in patients with malignant hematological diseases，and has a good negative predictive value in early diagnosis and exclusion of IFD. It can improve the efficiency and reduce the care burden of patient.

Key words: 1, 3-beta-D-glucan, Malignant hematological disease, Invasive fungal disease

CHEN Yan 1，WANG Shuhui 2，HUANG Baoqing 2，NI Xiong 3，HUANG Xiaochun 1，QIN Yanghua 1. Significance of plasma 1，3-beta-D-glucan assay for the diagnosis of invasive fungal diseases in patients with malignant hematological diseases[J]. , 2013, 28(1): 7-10.

References

[1]《中华内科杂志》编辑委员会. 血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(修订版)[J]. 中华内科杂志，2007，46(7)：607-610.
[2]黄晓军. 血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案）[J]. 中华内科杂志，2005，44(7)：554-556.
[3]Khan ZU，Ahmad S，Theyyathel AM. Detection of Aspergillus fumigatus-specific DNA，(1-3)-beta-D-glucan and galactomannan in serum and bronchoalveolar lavage specimens of experimentally infected rats[J]. Mycoses，2008，51(2)：129-135.
[4]Odabasi Z，Mattiuzzi G，Estey E，et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections：validation，cutoff development，and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome[J]. Clin Infect Dis，2004，39（2）：199-205.
[5]廖万清.侵袭性真菌感染的实验室诊断[J].检验医学，2010，25(7)：503-506.
[6]吕沛华，赵蓓蕾，施毅，等. 侵袭性肺部真菌感染动物模型制作及血浆β-葡聚糖检测的诊断价值[J]. 中华医院感染学杂志，2007，17(11)：1328-1331.
[7]Verweij PE，Figueroa J，Van Burik J，et al. Clinical applications of non-culture based methods for the diagnosis and management of opportunistic and endemic mycoses[J]. Med Mycol，2000，38(Suppl 1)：161-171.
[8]Pazos C，Pontn J，Del Palacio A. Contribution of（1-＞3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients：a comparison with serial screening for circulating galactomannan[J]. J Clin Microbiol，2005，43(1)：299-305.
[9]Persat F，Ranque S，Derouin F，et al. Contribution of the（1-＞3)-beta-D-glucan assay for diagnosis of invasive fungal infections[J]. J Clin Microbiol，2007，46(3)：1009-1013.
[10]De Pauw B，Walsh TJ，Donnelly JP，et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group（EORTC/MSG）Consensus Group[J]. Clin Infect Dis，2008，46(12)：1813-1821.
[11]Digby J，Kalbfleisch J，Glenn A，et al. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients[J]. Clin Diagn Lab Immunol，2003，10(5)：882-885.
[12]高蕾，周新. （1，3）-β-D葡聚糖检测在侵袭性真菌感染中的诊断意义[J]. 中国感染与化疗杂志，2008，8(2)：123-125.
[13]Aubry A，Porcher R，Bottero J，et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders[J]. J Clin Microbiol，2006，44(2)：389-394.
[14]Pickering JW，Sant HW，Bowles CA，et al. Evaluation of a（1-＞3)-beta-D-glucan assay for diagnosis of invasive fungal infections[J]. J Clin Microbiol，2005，43(12)：5957-5962.

[1]	YAO Yan, GU Juxian, LI Meng, LI Guoce, AI Jingyi, ZHAO Li. Diagnostic roles of transforming growth factor-beta-activated kinase 1 and autophagy-related protein 7 in cerebrospinal fluid of patients with tuberculous meningitis [J]. Laboratory Medicine, 2025, 40(9): 829-833.
[2]	ZHAO Lixiao, YANG Xiaoting, LI Dan, ZHANG Nan, SU Haiyan, WANG Yan. Diagnostic roles of serum syndecan-1 and eNAMPT levels in patients with severe pneumonia complicated with sepsis [J]. Laboratory Medicine, 2025, 40(9): 856-861.
[3]	FU Ai. Relationship between serum miR-125b and miR-423 expressions in patients with pulmonary tuberculosis and the disease activity and prognosis [J]. Laboratory Medicine, 2025, 40(9): 862-866.
[4]	CHEN Fujun, CHEN Maoming. Status of clinical research on pancreatic enzyme markers [J]. Laboratory Medicine, 2025, 40(9): 918-924.
[5]	GUO Manman, ZHANG Peng, WANG Runzhi, SHI Long. Correlation between the expression of serum lncRNA NEAT1，miR-29c-3p and the disease status，clinical prognosis of epilepsy in children [J]. Laboratory Medicine, 2025, 40(8): 763-768.
[6]	XU Lei, JIN Yiying, HUANG Nan, MA Ji, PAN Qiuhui. Influence of SULF1 expression on cell proliferation in gastric cancer [J]. Laboratory Medicine, 2025, 40(8): 810-816.
[7]	SHI Fangjing, HU Shanshan, LUO Xinguo, ZHU Yan, YU Fangquan, YE Hongwei. Expression of programmed death-1/programmed death-ligand 1 in chronic lymphocytic leukemia patients and its correlation with T lymphocyte subsets [J]. Laboratory Medicine, 2025, 40(6): 592-595.
[8]	QIAN Wenjun, WU Hongbin. Relationship between serum miR-146a-5p and miR-146b-5p expression levels and TLR4/NF-κB signaling pathway and prognosis in patients with LAA type cerebral infarction [J]. Laboratory Medicine, 2025, 40(5): 471-476.
[9]	SUN Haiqing, LIU Ning, LOU Jinli, YU Yanhua. Clinical role of STIP1 and AFP-L3 combined determination in diagnosing HCC [J]. Laboratory Medicine, 2025, 40(4): 324-330.
[10]	ZHU Jing, ZHANG Rulin, WU Jun. Expressions of CCNB1，PTTG1 and CBX3 in hepatocellular carcinoma and their roles in prognostic assessment [J]. Laboratory Medicine, 2025, 40(4): 331-337.
[11]	CHEN Weilong, WANG Yongbing, CHEN Zegang. Correlation between ZBED3，CYFRA21-1，VEGF and short-term mortality risk in patients with advanced liver cancer [J]. Laboratory Medicine, 2025, 40(4): 338-343.
[12]	ZHANG Guoying, LU Zhongkui, WANG Yuling, XIA Xia, MENG Ke, HE Fang, HUANG Zihui, YANG Zengmin, LIU Xin. Application of gamma-interferon inducible protein-10 mRNA determination technology in diagnosis of extrapulmonary tuberculosis [J]. Laboratory Medicine, 2025, 40(4): 372-376.
[13]	ZHENG Yong, LÜ Lei, HE Kai. Clinical roles of serum GDF15 and YKL-40 in elderly patients with gallbladder cancer [J]. Laboratory Medicine, 2025, 40(4): 377-382.
[14]	JIA Lingyan, XIE Shanli, CHEN Ze. Relationship between serum miR-370-3p and miR-152-5p expressions and clinical pathological characteristics and prognosis of ovarian cancer patients [J]. Laboratory Medicine, 2025, 40(3): 241-246.
[15]	SHU Ming. Roles of serum VCAM-1，Gal-3 and Hcy expression levels in evaluating patients with coronary heart disease [J]. Laboratory Medicine, 2025, 40(3): 247-252.